Silvercorp net income $43.7 million, $0.26 per share, for Fiscal 2017

VANCOUVER, May 25, 2017 - Silvercorp Metals Inc. ("Silvercorp" or the "Company") (TSX: SVM) (NYSE: SVM) reported its financial and operating results for the fourth quarter and twelve months ended March 31, 2017.  All amounts are expressed in US Dollars.
Net income attributable to equity shareholders of $43.7 million, or $0.26 per share1, up 589% compared to net income attributable to equity shareholders of $6.3 million, or $0.04 per share in the prior year. Adjusted net income2 attributable to equity shareholders of $38.6 million or $0.23 per share, up 509% from the prior year after adjustment to one-time net impairment reversal of $5.1 million;
Read more: Silvercorp Metals ( SVM )

Cellular Biomedicine Group (CBMG) Announces Publication Titled “Target cell killing effects of CD20 targeting chimeric antigen receptor T cells derived from the type II anti-CD20 antibody ” in Conjunction with 2017 ASCO Annual Meeting

SHANGHAI, China and CUPERTINO, Calif., May 19, 2017  -- Cellular Biomedicine Group Inc. (NASDAQ:CBMG) (“CBMG” or the “Company”), a clinical-stage biopharmaceutical firm engaged in the development of effective immunotherapies for cancer and stem cell therapies for degenerative diseases, today announced the publication of an abstract exploring the application of B-cell antigen, CD20, for targeted Chimeric Antigen Receptor T cells (CAR-T) therapy. The abstract has been published in conjunction with the 2017 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, June 2 – 6, 2017. 
Read more: Cellular Biomedicine Group ( CBMG )

ENSERVCO Reports First Quarter 2017 Financial Results

Revenue increases 66% to $13.8 million from $8.3 million year over year
Net income improved to $50,000 versus a net loss of $1.1 million year over year
Adjusted EBITDA increases 281% to $2.5 million from $661,000 year over year
Well enhancement service revenue increases 67% to $12.0 million from $7.2 million year over year
New water transfer service revenue increases 393% to $752,000 in Q1 from $153,000 in Q4 2016
Revenue from Eagle Ford expansion increases 61% to $1.4 million from $867,000 year over year
Read more: ENSERVCO Corporation ( ENSV )

Dynacor Produces 17,125 oz of Gold in Q1-2017

MONTREAL, QUEBEC--( April 20, 2017) - Dynacor Gold Mines Inc. (TSX:DNG) (OTC:DNGDF) (Dynacor or the Corporation) is pleased to report that its 1st quarter gold production reached 17,125 oz. This represents an increase of 1,318 ounces of gold, as compared to Q1-2016 (15,807 oz), despite the extreme weather conditions in northern and central Peru which has led to the destruction of many bridges and roads and localized severe flooding.
Total gold exported during Q1-2017 was 20,301 oz. 
Monthly gold production data in 2017 and 2016 for the first quarter are presented in the Table 1 below. As compared to 2016, gold production was higher in January (+15%) and reached an all-time high for a month of February (+31%) but due to the extreme weather and its impact, production was lower in March (-16%). Nevertheless, total quarterly gold production increased by 8.3% (1,318 oz). 
Read more: Dynacor Gold Mines ( DNG )

Ceapro Inc. Reports 2016 Financial Results and Provides Corporate Update

Company reports highest full year revenues in Company's history and continues to deliver strong performance
EDMONTON, ALBERTA--(April 6, 2017) -Ceapro Inc.(TSX VENTURE:CZO)("Ceapro" or the "Company"), a growth-stage biotechnology company focused on the development and commercialization of active ingredients for healthcare and cosmetic industries, today announced its financial results for the twelve months ended December 31, 2016 and provided a corporate update. The Company's 2016 financial results reveal the best year in Ceapro's history.
Financial Highlights for the Full Year 2016
Highest full year revenue and operating cash flows in Company's history;
Total sales of $13,674,000 for the full year 2016 compared to $10,667,000 in 2015, an increase of 28.2% year-over-year revenue performance;
Read more: Ceapro Inc ( CZO )

Videos / Webinars

View all videos